Bailey Jeffrey Allen is a director of Aurinia Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aurinia Pharmaceuticals Inc.
21 Aug 23
3
Aurinia Pharmaceuticals Inc.
21 Aug 23
4
AILERON THERAPEUTICS INC
17 Jun 22
4
BIODELIVERY SCIENCES INTERNATIONAL INC
22 Mar 22
4
BIODELIVERY SCIENCES INTERNATIONAL INC
11 Mar 22
4
BIODELIVERY SCIENCES INTERNATIONAL INC
31 Jan 22
4
BIODELIVERY SCIENCES INTERNATIONAL INC
8 Nov 21
4
BIODELIVERY SCIENCES INTERNATIONAL INC
10 Aug 21
4
AILERON THERAPEUTICS INC
17 Jun 21
4
Tekla World Healthcare Fund
8 Apr 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Aug 23 | AUPH Aurinia Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 9.49 | 28,959 | 274.82 k | 28,959 |
18 Aug 23 | AUPH Aurinia Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 17,913 | 0.00 | 17,913 |